Clincosm LogoSign in Get a demo

intrahepatic cholangiocarcinoma

Showing 1 - 25 of 87
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

Not yet recruiting
  • Carcinoma
  • +7 more
  • (no location specified)
Nov 12, 2023

Esophageal Cancer, Small Bowel Cancer, Gastroesophageal-junction Cancer Trial in Sacramento (Ablative local therapy)

Recruiting
  • Esophageal Cancer
  • +10 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 27, 2023

Intrahepatic Cholangiocarcinoma Trial in Padova (Liver transplantation)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Liver transplantation
  • Padova, Italy
    Azienda Ospedale Università di Padova
Oct 25, 2023

Intrahepatic Cholangiocarcinoma Trial (procedure, drug, biological)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Biopsy
  • +7 more
  • (no location specified)
Sep 21, 2023

Intrahepatic Cholangiocarcinoma Trial in Shanghai (HMPL-453, Rabeprazole)

Active, not recruiting
  • Intrahepatic Cholangiocarcinoma
  • Shanghai, Shanghai, China
    Shanghai Xuhui Central Hospital
Jun 24, 2023

Carcinoma, Intrahepatic Cholangiocarcinoma, Digestive System Tumors Trial in Guangzhou (Pemigatinib, PD-1 Inhibitors)

Recruiting
  • Carcinoma
  • +4 more
  • Guangzhou, Guangdong, China
    Lei Zhang
Jun 21, 2023

Biliary Tract Diseases, Gallbladder Cancer, Extrahepatic Bile Duct Cancer Trial (no interventions)

Not yet recruiting
  • Biliary Tract Diseases
  • +5 more
  • no interventions
  • (no location specified)
Jun 1, 2023

Intrahepatic Cholangiocarcinoma Trial in Shanghai (Cadonilimab+Gem/Cis)

Active, not recruiting
  • Intrahepatic Cholangiocarcinoma
  • Shanghai, Shanghai, China
    Eastern hepatobilliary surgery hospital
Mar 22, 2023

Esophageal Cancer, Head and Neck Squamous Cell Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma Trial (LSTA1,

Not yet recruiting
  • Esophageal Cancer
  • +9 more
  • (no location specified)
Feb 2, 2023

Multi-Platform Profiling of Resected Biliary Tract Cancer

Recruiting
  • Biliary Tract Cancer
  • +7 more
  • Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
  • Chicago, Illinois
  • +1 more
Jan 23, 2023

Intrahepatic Cholangiocarcinoma Trial (derazantinib)

Available
  • Intrahepatic Cholangiocarcinoma
  • (no location specified)
Jan 13, 2023

Therapeutic Assistance and Decision-making Algorithms in

Not yet recruiting
  • Hepatocellular Carcinoma
  • +5 more
  • ADBoard
  • Berlin, Germany
    Surgical Clinic, Campus Virchow-Klinikum / Campus Charité Mitte,
Jan 12, 2023

Hilar Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Common Bile Duct Tumors Trial in Rotterdam (Endoscopic Ultrasound

Recruiting
  • Hilar Cholangiocarcinoma
  • +4 more
  • Endoscopic Ultrasound registration
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus University Medical Center
Jan 11, 2023

Durvalumab, Intrahepatic Cholangiocarcinoma, Gemcis Trial in Tianjin (Durvalumab, Surgery, Gemcitabine)

Recruiting
  • Durvalumab
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jan 3, 2023

Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Duarte (Cisplatin, Gemcitabine,

Suspended
  • Distal Bile Duct Adenocarcinoma
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Predict Efficacy of GC in Treatment of Intrahepatic

Not yet recruiting
  • Organoids
  • Intrahepatic Cholangiocarcinoma
  • gemcitabine + cisplatin
  • (no location specified)
Nov 30, 2022

Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Liver Metastases Trial in Belgium, United Kingdom (MIV-818

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • MIV-818 (fostroxacitabine bralpamide) + pembrolizumab
  • MIV-818 (fostroxacitabine bralpamide) + lenvatinib
  • Antwerp, Belgium
  • +16 more
Nov 11, 2022

Intrahepatic Cholangiocarcinoma Trial in China, United States (Extend LymphAdenectomy)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Extend LymphAdenectomy
  • Baltimore, Maryland
  • +12 more
Nov 7, 2022

Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Houston (SD-101, Pembrolizumab, Nivolumab)

Recruiting
  • Hepatocellular Carcinoma
  • Intrahepatic Cholangiocarcinoma
  • New York, New York
  • +3 more
Oct 19, 2022

Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Frankfurt, Hannover, Jena (Delcath Hepatic Delivery System,

Terminated
  • Hepatocellular Carcinoma
  • Intrahepatic Cholangiocarcinoma
  • Frankfurt, Germany
  • +2 more
Oct 13, 2022

Intrahepatic Cholangiocarcinoma Trial in Oslo (Liver Transplant)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Liver Transplant
  • Oslo, Norway
    Oslo University Hospital
Oct 4, 2022

Intrahepatic Cholangiocarcinoma Trial in Hangzhou (Tislelizumab combined with GEMOX (GOT) regimen)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Tislelizumab combined with GEMOX (GOT) regimen
  • Hangzhou, Zhejiang, China
    1# Banshan East Rd. Zhejiang cancer hospital
Sep 24, 2022

Intrahepatic Cholangiocarcinoma Trial in Tianjin (Regorafenib and HAIC, FOLFOX)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Sep 7, 2022

Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen

Recruiting
  • Acinar Cell Carcinoma
  • +93 more
  • Biospecimen Collection
  • +2 more
  • Birmingham, Alabama
  • +998 more
Aug 23, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022